Company: ZVRA
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001434647-25-000011
Chunk: 48

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 1
Chunk 48
---
ITEM 1.FINANCIAL STATEMENTS

ZEVRA THERAPEUTICS, INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and par value amounts)

September 30,2025December 31,2024AssetsCurrent assets:Cash and cash equivalents$54,439 $33,785 Securities at fair value, current145,070 35,711 Accounts and other receivables16,841 10,509 Prepaid expenses and other current assets7,398 4,052 Inventories, current1,367 1,970 Total current assets225,115 86,027 Securities at fair value, noncurrent30,865 6,010 Inventories, noncurrent720 10,999 Property and equipment, net488 356 Operating lease right-of-use assets1,337 657 Goodwill4,701 4,701 Intangible assets, net6,737 68,993 Other long-term assets153 384 Total assets$270,116 $178,127 Liabilities and stockholders' equityCurrent liabilities:Accounts payable and accrued expenses$11,072 $25,456 Current portion of operating lease liabilities441 420 Current portion of discount and rebate liabilities5,609 4,989 Other current liabilities8,990 3,200 Total current liabilities26,112 34,065 Long-term debt61,310 59,504 Warrant liability13,767 17,804 Income tax payable17,464 14,431 Operating lease liabilities, less current portion966 372 Discount and rebate liabilities, less current portion13,337 7,655 Other long-term liabilities3,995 4,630 Total liabilities136,951 138,461 Commitments and contingencies (Note M)Stockholders’ equity:Preferred stock:Undesignated preferred stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued or outstanding as of September 30, 2025, or December 31, 2024— — Common stock, $0.0001 par value, 250,000,000 shares authorized; 57,793,414 shares issued and 56,217,722 shares outstanding as of September 30, 2025; 55,246,401 shares issued